CY1107937T1 - Προφαρμακα σε συνδετες υποδοχεα nmda - Google Patents
Προφαρμακα σε συνδετες υποδοχεα nmdaInfo
- Publication number
- CY1107937T1 CY1107937T1 CY20081100485T CY081100485T CY1107937T1 CY 1107937 T1 CY1107937 T1 CY 1107937T1 CY 20081100485 T CY20081100485 T CY 20081100485T CY 081100485 T CY081100485 T CY 081100485T CY 1107937 T1 CY1107937 T1 CY 1107937T1
- Authority
- CY
- Cyprus
- Prior art keywords
- nmda
- connectors
- products
- compounds
- lower alkyl
- Prior art date
Links
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 abstract 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Η εφεύρεση σχετίζεται με ενώσεις του γενικού τύπου (I) όπου το R είναι α) -C(O)(CH2)nC(O)OH, β) όπου το R1 είναι -N(R2)(R3) και τα R2/R3 είναι ανεξάρτητα μεταξύ τους υδρογόνο ή κατώτερη αλκυλομάδα, ή είναι κυκλική τριτοταγής αμίνη, προαιρετικά υποκατεστημένη με κατώτερη αλκυλομάδα, γ)-Ρ(Ο)(ΟΗ)2, ή δ) είναι -C(O) (CH2)nNHC(Ο)(CH2)nN(R2)(R3) και το n είναι 1, 2, 3 ή 4, και με φαρμακευτικώς αποδεκτά άλατα προσθήκης οξέος αυτών. Αυτές οι ενώσεις μπορούν να χρησιμοποιηθούν ως προφάρμακα για την μητρική ένωση του τύπου (II) οι οποίες είναι χρήσιμες στην θεραπευτική αντιμετώπιση παθήσεων που σχετίζονται με υποδοχέα NMDA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00117918 | 2000-08-21 | ||
| EP01965201A EP1313703B1 (en) | 2000-08-21 | 2001-08-20 | Prodrugs to nmda receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1107937T1 true CY1107937T1 (el) | 2013-09-04 |
Family
ID=8169594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081100485T CY1107937T1 (el) | 2000-08-21 | 2008-05-08 | Προφαρμακα σε συνδετες υποδοχεα nmda |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US6407235B1 (el) |
| EP (1) | EP1313703B1 (el) |
| JP (1) | JP4162991B2 (el) |
| KR (1) | KR100589991B1 (el) |
| CN (1) | CN1227230C (el) |
| AR (1) | AR030373A1 (el) |
| AT (1) | ATE386022T1 (el) |
| AU (2) | AU8589401A (el) |
| BR (1) | BR0113348A (el) |
| CA (1) | CA2419279C (el) |
| CY (1) | CY1107937T1 (el) |
| CZ (1) | CZ303319B6 (el) |
| DE (1) | DE60132782T2 (el) |
| DK (1) | DK1313703T3 (el) |
| EC (1) | ECSP034489A (el) |
| EG (1) | EG24293A (el) |
| ES (1) | ES2299508T3 (el) |
| HK (1) | HK1059083A1 (el) |
| HR (1) | HRP20030125B1 (el) |
| HU (1) | HU229802B1 (el) |
| IL (1) | IL154254A0 (el) |
| JO (1) | JO2289B1 (el) |
| MA (1) | MA26947A1 (el) |
| MX (1) | MXPA03001311A (el) |
| MY (1) | MY136065A (el) |
| NO (1) | NO324941B1 (el) |
| NZ (1) | NZ523990A (el) |
| PA (1) | PA8525601A1 (el) |
| PE (1) | PE20020291A1 (el) |
| PL (1) | PL204215B1 (el) |
| PT (1) | PT1313703E (el) |
| RS (1) | RS51467B (el) |
| RU (1) | RU2272027C2 (el) |
| SI (1) | SI1313703T1 (el) |
| WO (1) | WO2002016321A1 (el) |
| ZA (1) | ZA200300894B (el) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02009311A (es) * | 2000-03-21 | 2003-03-12 | Procter & Gamble | Inhibidores de las metaloproteasas n-sustituidas que contienen cadenas laterales heterociclicas. |
| US6713490B2 (en) | 2002-04-26 | 2004-03-30 | Pfizer, Inc. | 3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists |
| AU2006327892B2 (en) * | 2005-12-19 | 2011-12-22 | Methylgene Inc. | Histone deacetylase inhibitors for enhancing activity of antifungal agents |
| CA2672192A1 (en) | 2006-12-19 | 2008-06-26 | Methylgene Inc. | Inhibitors of histone deacetylase and prodrugs thereof |
| US8796330B2 (en) * | 2006-12-19 | 2014-08-05 | Methylgene Inc. | Inhibitors of histone deacetylase and prodrugs thereof |
| WO2015067923A1 (en) | 2013-11-05 | 2015-05-14 | Astrazeneca Ab | Nmda antagonist prodrugs |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4410822A1 (de) | 1994-03-24 | 1995-09-28 | Schering Ag | Neue Piperidin-Derivate |
| TW498067B (en) | 1996-07-19 | 2002-08-11 | Hoffmann La Roche | 4-hydroxy-piperidine derivatives |
| TWI254043B (en) | 1999-06-08 | 2006-05-01 | Hoffmann La Roche | Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor |
-
2001
- 2001-08-16 US US09/931,431 patent/US6407235B1/en not_active Expired - Lifetime
- 2001-08-16 PE PE2001000820A patent/PE20020291A1/es not_active Application Discontinuation
- 2001-08-16 PA PA20018525601A patent/PA8525601A1/es unknown
- 2001-08-17 AR ARP010103939A patent/AR030373A1/es active IP Right Grant
- 2001-08-17 MY MYPI20013876A patent/MY136065A/en unknown
- 2001-08-19 JO JO2001136A patent/JO2289B1/en active
- 2001-08-20 JP JP2002521197A patent/JP4162991B2/ja not_active Expired - Fee Related
- 2001-08-20 NZ NZ523990A patent/NZ523990A/en not_active IP Right Cessation
- 2001-08-20 MX MXPA03001311A patent/MXPA03001311A/es active IP Right Grant
- 2001-08-20 RS YUP-130/03A patent/RS51467B/sr unknown
- 2001-08-20 BR BR0113348-9A patent/BR0113348A/pt not_active Application Discontinuation
- 2001-08-20 DK DK01965201T patent/DK1313703T3/da active
- 2001-08-20 SI SI200130812T patent/SI1313703T1/sl unknown
- 2001-08-20 EP EP01965201A patent/EP1313703B1/en not_active Expired - Lifetime
- 2001-08-20 EG EG20010906A patent/EG24293A/xx active
- 2001-08-20 AU AU8589401A patent/AU8589401A/xx active Pending
- 2001-08-20 PL PL361387A patent/PL204215B1/pl unknown
- 2001-08-20 HU HU0301548A patent/HU229802B1/hu not_active IP Right Cessation
- 2001-08-20 IL IL15425401A patent/IL154254A0/xx not_active IP Right Cessation
- 2001-08-20 AU AU2001285894A patent/AU2001285894B2/en not_active Ceased
- 2001-08-20 RU RU2003107572/04A patent/RU2272027C2/ru not_active IP Right Cessation
- 2001-08-20 DE DE60132782T patent/DE60132782T2/de not_active Expired - Lifetime
- 2001-08-20 WO PCT/EP2001/009561 patent/WO2002016321A1/en active IP Right Grant
- 2001-08-20 KR KR1020037002485A patent/KR100589991B1/ko not_active IP Right Cessation
- 2001-08-20 AT AT01965201T patent/ATE386022T1/de active
- 2001-08-20 PT PT01965201T patent/PT1313703E/pt unknown
- 2001-08-20 CN CNB01814361XA patent/CN1227230C/zh not_active Expired - Fee Related
- 2001-08-20 ES ES01965201T patent/ES2299508T3/es not_active Expired - Lifetime
- 2001-08-20 CZ CZ20030492A patent/CZ303319B6/cs not_active IP Right Cessation
- 2001-08-20 CA CA002419279A patent/CA2419279C/en not_active Expired - Fee Related
-
2003
- 2003-01-31 ZA ZA200300894A patent/ZA200300894B/en unknown
- 2003-02-19 NO NO20030781A patent/NO324941B1/no not_active IP Right Cessation
- 2003-02-20 EC EC2003004489A patent/ECSP034489A/es unknown
- 2003-02-20 HR HR20030125A patent/HRP20030125B1/xx not_active IP Right Cessation
- 2003-02-21 MA MA27052A patent/MA26947A1/fr unknown
-
2004
- 2004-03-16 HK HK04101906A patent/HK1059083A1/xx not_active IP Right Cessation
-
2008
- 2008-05-08 CY CY20081100485T patent/CY1107937T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1485359T3 (da) | Natriumkanalblokkere | |
| CY1107937T1 (el) | Προφαρμακα σε συνδετες υποδοχεα nmda | |
| BR0314227A (pt) | Derivados de amido de hidroxialquila | |
| HUP0402507A2 (hu) | N(fenilszulfonil)glicin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények | |
| DK633088A (da) | Kollagenaseinhibitorer | |
| CY1109220T1 (el) | Παραγωγα ν-ακυλαμινοβενζολιου ως εκλεκτικοι αναστολεις της οξειδασης μονοαμινης β | |
| CO5650218A2 (es) | Composiciones de enjuague bucal que contienen sales del alquil ester de n-acil arginina | |
| CO4980887A1 (es) | Nueva 3,4-diariltiazolina-2-uno o 2-tiono derivados, sus metodos de preparacion y su uso terapeutico | |
| FI101301B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi | |
| NO954609D0 (no) | Niopecotiske syrederivater som antitrombiske forbindelser | |
| IT1275997B1 (it) | Enammine come accelleranti di vulcanizzazione per gomme naturali o sintetiche | |
| UA40573C2 (uk) | Похідні 2-ціано-3-гідроксипропенаміду, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі | |
| DK1347965T3 (da) | Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf | |
| AR019197A1 (es) | COMPUESTOS DERIVADOS DE PIPERIDINA ANTIHISTAMINICOS, COMPUESTOS INTERMEDIOS, PROCEDIMIENTO DE PREPARACIoN DE DERIVADOS DE PIPERIDINA Y PROCEDIMIENTOS DE PREPARACIoN DE INTERMEDIARIOS. | |
| DE69405439T2 (de) | Verfahren zur Herstellung von Aminotriazin-Derivaten | |
| CY1105422T1 (el) | Νεα πιπepιδινυλο-αλκυλαμινο-πυριδαζινονικα παραγωγα, μια διαδικασια για την παρασκευη τους και φαρμακευτικες συνθεσεις οι οποιες πepιεχουν τις εν λογω ενωσεις | |
| ATE6500T1 (de) | 2-alpha-methyl-dopaminimino-6,7-dihydroxy-1,2,3 4-tetrahydronaphthalin, seine salze, und verfahren zu dessen herstellung. | |
| ITMI913400A1 (it) | Acidi triazinilfosfonici e loro impiego in composizioni polimeriche autoestinguenti. | |
| DE69527854D1 (de) | Derivate substituierter amidinonaphthylester | |
| GR930100500A (el) | Παράγωγα φαινυλοξικού οξέως, διεργασία για την παρασκευή τους και αντίστοιχη χρήση. | |
| FR2794122B1 (fr) | Nouveaux antioxydants, procedes de preparation et utilisations | |
| DE69904940T2 (de) | 6-deoxy-erythromycin-derivate, ihrer herstellung, und ihrer verwendung als arzneimitteln | |
| FR2609464B1 (fr) | Nouveaux derives du n-(1h-indol 4-yl) benzamide ainsi que leurs sels, leur application a titre de medicaments, et les compositions les renfermant | |
| ES433894A1 (es) | Procedimiento para la preparacion de nuevas bencilaminas. | |
| ATE98635T1 (de) | Sterisch gehinderte aminoverbindungen und verfahren zu deren herstellung. |